-
Review
January 22, 2025
- Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
- Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
- Clin Mol Hepatol. 2025;31(3):685-705.
Review
January 22, 2025
Review
February 5, 2025
Review
March 26, 2025
Review
April 2, 2025
Review
April 16, 2025
Original Article
January 6, 2025
Original Article
January 17, 2025
Original Article
January 22, 2025
Original Article
February 5, 2025
Original Article
February 5, 2025
Original Article
February 5, 2025
Original Article
February 5, 2025
Original Article
February 6, 2025
Original Article
February 10, 2025
Original Article
March 4, 2025
Original Article
March 11, 2025
Original Article
March 17, 2025
Original Article
April 4, 2025
Original Article
April 11, 2025
Original Article
April 11, 2025
Original Article
April 21, 2025
Original Article
April 23, 2025
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
07 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 12523 |
Epidemiology of metabolic dysfunction-associated steatotic liver disease |
Viewed By 7621 |
Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target |
Viewed By 7103 |
MAFLD: How is it different from NAFLD? |
Viewed By 5676 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 5560 |
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment |
Cited By 366 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 354 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 232 |
MAFLD: How is it different from NAFLD? |
Cited By 122 |
Non-alcoholic fatty liver disease: Definition and subtypes |
Cited By 116 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |